Lansoprazole CAS No.103577-45-3 / Cat No.EBD25007
lansoprazole
2-{[[3-methyl-4-(2,2,2-trifluoroethoxy)2-pyridinyl]methyl]sulfonyl}1H-benzimidazole
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole
1-(1H-benzimidazol-2-yl)-2-[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]ethanone
lansoprazile
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole
1-(1H-benzimidazol-2-yl)-2-[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]ethanone
lansoprazile
2-[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzoimidazole
Lansoprazole
Properties
-
Appearance:
white crystalline powder
-
Density:
1.5 g/cm3
-
Melting point:
178-182°C dec.
-
Boiling point:
555.8 °C at 760 mmHg
-
Flashing point:
289.9 °C
-
Storage temperature:
2-8°C
Safety Information
-
Symbol:
-
Signal words:
Warning -
Hazard statements:
H315 Causes skin irritation.
H319 Causes serious eye irritation.
H335 May cause respiratory irritation.
-
Precautionary statements:
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
NMR Spectrum
Prediction： 1H-NMR oe: 11.90 (bs, 1H, NH), 8.34 (d, J=5.7 Hz, 1H, C5H2N), 7.77 (bs, 1H, C6H4), 7.46 (bs, 1H, C6H4), 7.33-7.30 (m, 2H, C6H4), 6.66 (d, J=5.7 Hz, 1H, C5H2N), 4.79 (q, JHF=19.0 Hz, 2H, CH2CF3), 4.37-4.32 (m, 2H, CH2SO), 2.19 (s, 3H, CH3);
1H NMR
13C NMR
